Reagena Oy Ltd - Product Pipeline Analysis

Summary

Reagena Oy Ltd (Reagena) is a medical device company, offers vitro diagnostic products such as different reagents and test kits for the health care market. The company's lead product ReaMobile, a diagnostic platform serodiagnostic rapid tests used in staining solutions, clinical chemistry reagents in OEM and others. The product portfolio of company includes Reagena EIA tests, Reagena POC rapid tests, and ReaScan diagnostic system. It offer product to life science industry, used in production, quality control, product development and analytics. Reagena's product development, manufacturing and logistics are located in Finland, offer products through a network of distributors across worldwide.

This report is a source for data, analysis and actionable intelligence on the Reagena Oy Ltd portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Reagena Oy Ltd - Major Products and Services 5
Reagena Oy Ltd Pipeline Products by Equipment Type 6
Reagena Oy Ltd Pipeline Products by Development Stage 8
Reagena Oy Ltd Pipeline Products by Therapy Area 10
Reagena TBE IgG EIA Kit 12
Reagena TBE IgG EIA Kit Product Status 12
Reagena TBE IgG EIA Kit Product Description 12
Reagena TBE IgG EIA Kit Product Patent Details 12
Reagena TBE IgM EIA Kit 15
Reagena TBE IgM EIA Kit Product Status 15
Reagena TBE IgM EIA Kit Product Description 15
ReaScan DOBRAVA-HANTAAN IgM Kit 16
ReaScan DOBRAVA-HANTAAN IgM Kit Product Status 16
ReaScan DOBRAVA-HANTAAN IgM Kit Product Description 16
Reagena Oy Ltd - Key Competitors 17
Reagena Oy Ltd - Key Employees 18
Reagena Oy Ltd - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Reagena Oy Ltd, Recent Developments 20
Aug 24, 2011: Reagena Announces Publication Of ReaScan Reader In European Infectious Disease Journal 20
Apr 19, 2011: Reagena Leverages ReaScan Mobile Technology In New Applications 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables

List of Tables
Reagena Oy Ltd, Key Facts 1
Reagena Oy Ltd Key Pipeline Products by Equipment Type 1
Reagena Oy Ltd Key Pipeline Products by Therapy Area 1
Reagena Oy Ltd Key Pipeline Products by Development Stage 1
Reagena Oy Ltd, Key Facts 4
Reagena Oy Ltd, Major Products and Services 5
Reagena Oy Ltd Number of Pipeline Products by Equipment Type 6
Reagena Oy Ltd Pipeline Products by Equipment Type 7
Reagena Oy Ltd Number of Pipeline Products by Development Stage 8
Reagena Oy Ltd Pipeline Products by Development Stage 9
Reagena Oy Ltd Number of Pipeline Products by Therapy Area 10
Reagena Oy Ltd Pipeline Products by Therapy Area 11
Reagena TBE IgG EIA Kit - Product Status 12
Reagena TBE IgG EIA Kit - Product Description 12
Reagena TBE IgG EIA Kit - Patent Details 12
Reagena TBE IgM EIA Kit - Product Status 15
Reagena TBE IgM EIA Kit - Product Description 15
ReaScan DOBRAVA-HANTAAN IgM Kit - Product Status 16
ReaScan DOBRAVA-HANTAAN IgM Kit - Product Description 16
Reagena Oy Ltd, Key Employees 18
Reagena Oy Ltd, Subsidiaries 19

List of Figures

List of Figures
Reagena Oy Ltd Pipeline Products by Equipment Type 6
Reagena Oy Ltd Pipeline Products by Development Stage 8
Reagena Oy Ltd Pipeline Products by Therapy Area 10